PREDICTSURE
LIVE

Serial Number

79259194

Owner

PredictImmune Ltd.

Attorney

Shoko Naruo

Filing Date

Dec 18, 2018

Add to watchlist:

No watchlists yet
View on USPTO

PREDICTSURE Trademark

Serial Number: 79259194 • Registration: 6039264

PREDICTSURE is a trademark filed by PredictImmune Ltd. on December 18, 2018. The trademark is classified under Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently registered and active.

Owner Contact Info

PredictImmune Ltd.

Finsgate, 5-7 Cranwood Street

Entity Type: 99

Trademark Details

Filing Date

December 18, 2018

Registration Date

April 28, 2020

Published for Opposition

February 11, 2020

Goods & Services

Diagnostic and prognostic reagents and preparations for medical purposes; diagnostic and prognostic reagents and preparations for laboratory testing for medical purposes, including laboratory testing of samples from patients

Medical services, including diagnostic and prognostic services, guiding treatment options; RNA and DNA analysis, namely, genetic testing for medical purposes; medical analysis services for the diagnosis, prognosis and treatment of persons provided by medical laboratories

Diagnostic and prognostic apparatuses, devices and instruments for the testing of patient samples for analyzing immune-related diseases; diagnostic and prognostic test kits comprising test tubes, test plates, reagents and indicator diagrams, for the testing of patient samples for analyzing immune-related diseases; diagnostic and prognostic apparatuses, devices and instruments for medical testing purposes in relation to immune-related diseases including inflammatory bowel disease, Crohn's disease, ulcerative colitis; diagnostic and prognostic test kits comprising test tubes, test plates, reagents and indicator diagrams, for medical testing purposes in relation to immune-related diseases including inflammatory bowel disease, Crohn's disease, ulcerative colitis

Computer-aided diagnostic and prognostic testing services, including analyzing samples from patients to provide diagnosis and prognosis and guiding treatment options, namely, medical laboratory services; software as a service (Saas) services featuring software for diagnosis and prognosis of immune-related diseases; software as a service (SaaS) services featuring software for providing diagnostic or prognostic results and guiding treatment options based on data from patient samples; design and development of diagnostic and prognostic apparatus, devices, kits and instruments; medical and scientific research, design and development of diagnostic and prognostic tests, including diagnostic and prognostic tests relating to immune-related diseases including inflammatory bowel disease, Crohn's disease, ulcerative colitis

Filing History

COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Apr 28, 2025 REM3
NEW REPRESENTATIVE AT IB RECEIVED
Feb 12, 2024 NREP
FINAL DECISION TRANSACTION PROCESSED BY IB
Sep 26, 2020 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Sep 6, 2020 FICS
FINAL DISPOSITION PROCESSED
Aug 31, 2020 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Jul 28, 2020 FICR
REGISTERED-PRINCIPAL REGISTER
Apr 28, 2020 R.PR
NOTIFICATION PROCESSED BY IB
Feb 14, 2020 GPNX
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Feb 11, 2020 NPUB
PUBLISHED FOR OPPOSITION
Feb 11, 2020 PUBO
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Jan 29, 2020 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Jan 29, 2020 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jan 22, 2020 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jan 2, 2020 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Dec 19, 2019 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Dec 18, 2019 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Dec 18, 2019 TROA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Dec 17, 2019 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Dec 17, 2019 REAP
REFUSAL PROCESSED BY IB
Jul 12, 2019 RFNP
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Jun 22, 2019 RFCS
REFUSAL PROCESSED BY MPU
Jun 22, 2019 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Jun 4, 2019 RFCR
NON-FINAL ACTION WRITTEN
Jun 3, 2019 CNRT
APPLICATION FILING RECEIPT MAILED
Jun 1, 2019 MAFR
ASSIGNED TO EXAMINER
May 28, 2019 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
May 28, 2019 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
May 23, 2019 REPR